Agilent Technologies, Inc. $A Shares Sold by Logan Capital Management Inc.

Logan Capital Management Inc. reduced its position in Agilent Technologies, Inc. (NYSE:A) by 5.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 95,192 shares of the medical research company’s stock after selling 5,745 shares during the period. Logan Capital Management Inc.’s holdings in Agilent Technologies were worth $11,234,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in A. Vanguard Group Inc. raised its holdings in shares of Agilent Technologies by 0.7% in the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company’s stock worth $3,908,141,000 after purchasing an additional 240,965 shares during the period. Pictet Asset Management Holding SA increased its position in Agilent Technologies by 2.5% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company’s stock worth $624,888,000 after purchasing an additional 128,131 shares in the last quarter. Generation Investment Management LLP raised its holdings in Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after buying an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Agilent Technologies by 18.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after buying an additional 604,124 shares in the last quarter. Finally, Nordea Investment Management AB grew its stake in Agilent Technologies by 16.2% during the second quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after buying an additional 447,207 shares during the period.

Analyst Upgrades and Downgrades

A has been the topic of a number of research reports. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Wells Fargo & Company raised their price objective on Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Barclays boosted their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Trading Down 0.8%

Shares of A opened at $146.82 on Tuesday. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The stock has a 50-day moving average price of $130.95 and a 200 day moving average price of $119.71. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The company has a market capitalization of $41.62 billion, a P/E ratio of 34.47, a P/E/G ratio of 4.83 and a beta of 1.26.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.